Monoclonal Antibody to PACAP for Migraine Prevention - Part 2
In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention. Show…
Read the full articleYou might also wanna read
CGRP monoclonal antibody fremanezumab may reduce weather-triggered migraine attacks, study finds
Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention
mdsc.pe·21d agoStudy to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom
Conditions : Migraine Sponsors : AbbVie Not yet recruiting
clinicaltrials.gov·9d ago
Rimegepant Effective in Treatment-Resistant Migraine
Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.
Medscape·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.